4

PRIMARY DOCUMENT

Company: CTT PHARMACEUTICAL HOLDINGS, INC.
Filed: January 30, 2023
Period of Report: January 30, 2023
Accession Number: 0001035422-23-000002

View Document ↗ View on SEC.gov ↗